The tub of white powder sitting in gym bags across the world might have a plot twist nobody saw coming.
UCLA researchers just found that creatine — yes, that creatine — could help the immune system fight cancer.
And it might make immunotherapy work better.
🤯
Let that land for a second.
The same scoop bodybuilders stir into their shakes…
may one day sit next to cancer treatment protocols.
Published in iScience, the study zoomed in on something called dendritic cells.
Think of them as the coaches of your immune system.
They spot the enemy. They rally the killer T cells. They call the plays.
And it turns out — these coaches run on creatine.
"Creatine doesn't just help the T cells fighting cancer," said immunologist Lili Yang. "It also energises the entire system that supports them."
Immunotherapy is one of the most exciting weapons in modern oncology.
But here's the catch — it only works for a fraction of patients.
If a $15 tub of powder could nudge those odds higher…
that changes the math on cancer care globally.
And creatine is everywhere.
The global creatine market is already worth around $1.4 billion and is projected to explode past $12 billion by 2035.
It's cheap. It's studied. It's on every supplement shelf from Mumbai to Manhattan.
Before anyone empties Amazon's creatine aisle — pump the brakes.
This was tested in:
Not human patients. Not yet.
Clinical trials are the next step. And the researchers were crystal clear:
👉 Cancer patients should not self-prescribe creatine without their doctor.
Safe for gym rats ≠ safe for someone mid-chemo.
Some of the most powerful medical breakthroughs don't come from exotic new molecules.
They come from hiding-in-plain-sight compounds we already trust.
Aspirin. Metformin. Now maybe… creatine.
If the human trials hold up, one of the most boring supplements on earth could quietly become one of the most interesting tools in the fight against cancer.
The gym bro stack just got a whole lot more serious.
That's all for now!
